Latest Articles
- CABG or PCI? A cardiothoracic surgeon’s perspective
The preference for treating multivessel coronary disease with percutaneous interventions is not justified.
- New therapies for type 2 diabetes based on glucagon-like peptide 1
Several new agents are under development, and one has been approved. They will be attractive for a number of reasons.
- Side effects of antidepressants: An overview
Noncompliance with antidepressant treatment remains worrisome. Educating and reassuring patients about potential side effects promotes effective treatment.
- Assessing the risk of surgery in patients with liver disease
All liver disease is not the same, and neither is all surgery, but recent studies have defined objective criteria for determining when surgery is safe for patients with liver disease.
- Do thiazolidinediones cause heart failure? A critical review
Although these drugs cause fluid retention, they may have benefits in patients with heart failure. This article outlines how to monitor for and manage side effects.
- Should all patientswith chronic kidney disease receive an EPO-type drug?
Many patients either do not receive these drugs or have low hemoglobin levels despite treatment. Thus, there are opportunities for better management.
